Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2022

18.08.2022 | Thoracic Oncology

A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients

verfasst von: Zihuai Wang, MD, Zhenyu Yang, MD, Sijia Li, MD, Junqi Zhang, MD, Liang Xia, MD, Jian Zhou, MD, Nan Chen, MD, Chenglin Guo, MD, Lunxu Liu, MD, PhD, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The revision of the N descriptor in non-small-cell lung cancer has been widely discussed in the past few years. Many different subclassification methods based on number or location of lymph nodes have been proposed for better distinguishing different N patients. This study aimed to systematically collect them and provide a comprehensive comparison among different subclassification methods in a large cohort.

Method

Pathological N1 or N2 non-small-cell lung cancer patients undergoing surgical resection between 2005 and 2016 in the Western China Lung Cancer Database were retrospectively reviewed. A literature review was conducted to collect previous subclassification methods. Kaplan-Meier and multivariable Cox analyses were used to examine the prognostic performance of subclassification methods. Decision curve analysis, Akaike’s information criterion, and area under the receiver operating curve concordance were also performed to evaluate the standardized net benefit of the subclassification methods.

Results

A total of 1625 patients were identified in our cohort. Eight subclassification methods were collected from previous articles and further grouped into subclassification based on number categories (node number or station number), location categories (lymph node zone or chain) or combination of number and location categories. Subclassification based on combination of lymph node location and number tended to have better discrimination ability in multivariable Cox analysis. No significant superiority among the different subclassification methods was observed in the three statistical models.

Conclusion

Subclassification based on the combination of location and number could be used to provide a more accurate prognostic stratification in surgically resected NSCLC and is worth further validation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51.CrossRefPubMed Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51.CrossRefPubMed
2.
Zurück zum Zitat Rusch VW, Crowley J, Giroux DJ, et al. The IASLC lung cancer staging project: proposals for the Revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2(7):603–12.CrossRefPubMed Rusch VW, Crowley J, Giroux DJ, et al. The IASLC lung cancer staging project: proposals for the Revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2(7):603–12.CrossRefPubMed
3.
Zurück zum Zitat Asamura H, Chansky K, Crowley J, et al. The international association for the study of lung cancer lung cancer staging project. J Thorac Oncol. 2015;10(12):1675–84.CrossRefPubMed Asamura H, Chansky K, Crowley J, et al. The international association for the study of lung cancer lung cancer staging project. J Thorac Oncol. 2015;10(12):1675–84.CrossRefPubMed
4.
Zurück zum Zitat Park BJ, Kim TH, Shin S, et al. Recommended change in the N descriptor proposed by the international association for the study of lung cancer: a validation study. J Thorac Oncol. 2019;14(11):1962–9.CrossRefPubMed Park BJ, Kim TH, Shin S, et al. Recommended change in the N descriptor proposed by the international association for the study of lung cancer: a validation study. J Thorac Oncol. 2019;14(11):1962–9.CrossRefPubMed
5.
Zurück zum Zitat Chiappetta M, Lococo F, Leuzzi G, et al. External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy. Eur J Cardiothorac Surg. 2020;58(6):1236–44.CrossRefPubMed Chiappetta M, Lococo F, Leuzzi G, et al. External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy. Eur J Cardiothorac Surg. 2020;58(6):1236–44.CrossRefPubMed
6.
Zurück zum Zitat Chen W, Zhang C, Wang G, Yu Z, Liu H. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations. Thorac Cancer. 2019;10(7):1533–43.CrossRefPubMedPubMedCentral Chen W, Zhang C, Wang G, Yu Z, Liu H. Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations. Thorac Cancer. 2019;10(7):1533–43.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Yun JK, Lee GD, Choi S, et al. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the international association for the study of lung cancer in surgically resected patients with non-small-cell lung cancer. Eur J Cardiothorac Surg. 2019;56(5):849–57.CrossRefPubMed Yun JK, Lee GD, Choi S, et al. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the international association for the study of lung cancer in surgically resected patients with non-small-cell lung cancer. Eur J Cardiothorac Surg. 2019;56(5):849–57.CrossRefPubMed
8.
Zurück zum Zitat Yu Y, Zhang P, Yao R, et al. Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study. Transl Lung Cancer Res. 2020;9(4):1285–301.CrossRefPubMedPubMedCentral Yu Y, Zhang P, Yao R, et al. Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study. Transl Lung Cancer Res. 2020;9(4):1285–301.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Tsitsias T, Okiror L, Veres L, et al. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery. Lung Cancer. 2021;151:84–90.CrossRefPubMed Tsitsias T, Okiror L, Veres L, et al. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery. Lung Cancer. 2021;151:84–90.CrossRefPubMed
10.
Zurück zum Zitat Xu L, Su H, She Y, et al. Which N descriptor is more predictive of prognosis in resected non-small cell lung cancer: the number of involved nodal stations or the location-based pathological N stage? Chest. 2021;159(6):2458–69.CrossRefPubMed Xu L, Su H, She Y, et al. Which N descriptor is more predictive of prognosis in resected non-small cell lung cancer: the number of involved nodal stations or the location-based pathological N stage? Chest. 2021;159(6):2458–69.CrossRefPubMed
11.
Zurück zum Zitat Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.CrossRefPubMed Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.CrossRefPubMed
12.
Zurück zum Zitat Liu C, Wei S, Guo C, Mei J, Pu Q, Liu L. Clinical significance of station 3A lymph node dissection in patients with right-side non-small-cell lung cancer: a retrospective propensity-matched analysis. Annal Surg Oncol. 2021;28(1):194–202.CrossRef Liu C, Wei S, Guo C, Mei J, Pu Q, Liu L. Clinical significance of station 3A lymph node dissection in patients with right-side non-small-cell lung cancer: a retrospective propensity-matched analysis. Annal Surg Oncol. 2021;28(1):194–202.CrossRef
13.
Zurück zum Zitat Aksoy Y, Çıtak N, Obuz Ç, Metin M, Sayar A. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients? Interact Cardiovasc Thorac Surg. 2021;33(4):541–9.CrossRefPubMedPubMedCentral Aksoy Y, Çıtak N, Obuz Ç, Metin M, Sayar A. Does anatomical location-based metastatic lymph node density affect prognosis in lung cancer patients? Interact Cardiovasc Thorac Surg. 2021;33(4):541–9.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bertoglio P, Ricciardi S, Alì G, et al. N2 lung cancer is not all the same: an analysis of different prognostic groups. Interact CardioVascular Thorac Surg. 2018;27(5):720–6.CrossRef Bertoglio P, Ricciardi S, Alì G, et al. N2 lung cancer is not all the same: an analysis of different prognostic groups. Interact CardioVascular Thorac Surg. 2018;27(5):720–6.CrossRef
15.
Zurück zum Zitat Kojima H, Terada Y, Yasuura Y, et al. Prognostic impact of the number of involved lymph node stations in patients with completely resected non-small cell lung cancer: a proposal for future revisions of the N classification. Gen Thorac Cardiovasc Surg. 2020;68(11):1298–304.CrossRefPubMed Kojima H, Terada Y, Yasuura Y, et al. Prognostic impact of the number of involved lymph node stations in patients with completely resected non-small cell lung cancer: a proposal for future revisions of the N classification. Gen Thorac Cardiovasc Surg. 2020;68(11):1298–304.CrossRefPubMed
16.
Zurück zum Zitat Baba T, Uramoto H, Kuwata T, et al. Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2012;14(6):760–4.CrossRefPubMedPubMedCentral Baba T, Uramoto H, Kuwata T, et al. Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2012;14(6):760–4.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Demir A, Turna A, Kocaturk C, et al. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Ann Thorac Surg. 2009;87(4):1014–22.CrossRefPubMed Demir A, Turna A, Kocaturk C, et al. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Ann Thorac Surg. 2009;87(4):1014–22.CrossRefPubMed
18.
Zurück zum Zitat Eichhorn F, Klotz LV, Muley T, Kobinger S, Winter H, Eichhorn ME. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis. Lung Cancer. 2019;138:95–101.CrossRefPubMed Eichhorn F, Klotz LV, Muley T, Kobinger S, Winter H, Eichhorn ME. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis. Lung Cancer. 2019;138:95–101.CrossRefPubMed
19.
Zurück zum Zitat Zheng H, Wang LM, Bao F, et al. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite. Lung Cancer. 2011;74(3):497–503.CrossRefPubMed Zheng H, Wang LM, Bao F, et al. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite. Lung Cancer. 2011;74(3):497–503.CrossRefPubMed
20.
Zurück zum Zitat Li S, Yan S, Lu F, et al. Validation of the 8th edition nodal staging and proposal of new nodal categories for future edition of the TNM classification of non-small cell lung cancer. Ann Surg Oncol. 2021;28(8):4510–6.CrossRefPubMed Li S, Yan S, Lu F, et al. Validation of the 8th edition nodal staging and proposal of new nodal categories for future edition of the TNM classification of non-small cell lung cancer. Ann Surg Oncol. 2021;28(8):4510–6.CrossRefPubMed
21.
Zurück zum Zitat Ding X, Hui Z, Dai H, et al. A proposal for combination of lymph node ratio and anatomic location of involved lymph nodes for nodal classification in non-small cell lung cancer. J Thorac Oncol. 2016;11(9):1565–73.CrossRefPubMed Ding X, Hui Z, Dai H, et al. A proposal for combination of lymph node ratio and anatomic location of involved lymph nodes for nodal classification in non-small cell lung cancer. J Thorac Oncol. 2016;11(9):1565–73.CrossRefPubMed
22.
Zurück zum Zitat Jonnalagadda S, Smith C, Mhango G, Wisnivesky JP. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer. Chest. 2011;140(2):433–40.CrossRefPubMedPubMedCentral Jonnalagadda S, Smith C, Mhango G, Wisnivesky JP. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer. Chest. 2011;140(2):433–40.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lee JG, Lee CY, Park IK, et al. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg. 2008;85(1):211–5.CrossRefPubMed Lee JG, Lee CY, Park IK, et al. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg. 2008;85(1):211–5.CrossRefPubMed
24.
Zurück zum Zitat Li F, Yuan L, Zhao Y, Wang S, Lv Z, Mao Y. Comparison of two proposed changes to the current nodal classification for non-small cell lung cancer based on the number and ratio of metastatic lymph nodes. Chest. 2021;160(4):1520–33.CrossRefPubMed Li F, Yuan L, Zhao Y, Wang S, Lv Z, Mao Y. Comparison of two proposed changes to the current nodal classification for non-small cell lung cancer based on the number and ratio of metastatic lymph nodes. Chest. 2021;160(4):1520–33.CrossRefPubMed
25.
Zurück zum Zitat Maniwa T, Ohmura A, Hiroshima T, et al. Number of metastatic lymph nodes and zones as prognostic factors in non-small-cell lung cancer. Interact Cardiovasc Thorac Surg. 2020;31(3):305–14.CrossRefPubMed Maniwa T, Ohmura A, Hiroshima T, et al. Number of metastatic lymph nodes and zones as prognostic factors in non-small-cell lung cancer. Interact Cardiovasc Thorac Surg. 2020;31(3):305–14.CrossRefPubMed
26.
Zurück zum Zitat Saji H, Tsuboi M, Shimada Y, et al. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer. Chest. 2013;143(6):1618–25.CrossRefPubMed Saji H, Tsuboi M, Shimada Y, et al. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer. Chest. 2013;143(6):1618–25.CrossRefPubMed
27.
Zurück zum Zitat Lee GD, Kim DK, Moon DH, et al. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2016;49(2):580–8.CrossRefPubMed Lee GD, Kim DK, Moon DH, et al. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2016;49(2):580–8.CrossRefPubMed
28.
Zurück zum Zitat Pawełczyk K, Marciniak M, Błasiak P. Evaluation of new classifications of N descriptor in non-small cell lung cancer (NSCLC) based on the number and the ratio of metastatic lymph nodes. J Cardiothorac Surg. 2016;11(1):68.CrossRefPubMedPubMedCentral Pawełczyk K, Marciniak M, Błasiak P. Evaluation of new classifications of N descriptor in non-small cell lung cancer (NSCLC) based on the number and the ratio of metastatic lymph nodes. J Cardiothorac Surg. 2016;11(1):68.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Deng W, Xu T, Wang Y, et al. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer. Lung Cancer. 2018;122:60–6.CrossRefPubMed Deng W, Xu T, Wang Y, et al. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer. Lung Cancer. 2018;122:60–6.CrossRefPubMed
30.
Zurück zum Zitat Dziedzic D, Piotr R, Langfort R, Orlowski T. Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. Surg Oncol. 2017;26(1):80–5.CrossRefPubMed Dziedzic D, Piotr R, Langfort R, Orlowski T. Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. Surg Oncol. 2017;26(1):80–5.CrossRefPubMed
31.
Zurück zum Zitat Smeltzer MP, Faris NR, Ray MA, Osarogiagbon RU. Association of pathologic nodal staging quality with survival among patients with non-small cell lung cancer after resection with curative intent. JAMA Oncol. 2018;4(1):80.CrossRefPubMed Smeltzer MP, Faris NR, Ray MA, Osarogiagbon RU. Association of pathologic nodal staging quality with survival among patients with non-small cell lung cancer after resection with curative intent. JAMA Oncol. 2018;4(1):80.CrossRefPubMed
32.
Zurück zum Zitat Smeltzer MP, Faris N, Yu X, et al. Missed intrapulmonary lymph node metastasis and survival after resection of non-small cell lung cancer. Ann Thorac Surg. 2016;102(2):448–53.CrossRefPubMedPubMedCentral Smeltzer MP, Faris N, Yu X, et al. Missed intrapulmonary lymph node metastasis and survival after resection of non-small cell lung cancer. Ann Thorac Surg. 2016;102(2):448–53.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Ramirez RA, Wang CG, Miller LE, et al. Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer. J Clin Oncol. 2012;30(23):2823–8.CrossRefPubMed Ramirez RA, Wang CG, Miller LE, et al. Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer. J Clin Oncol. 2012;30(23):2823–8.CrossRefPubMed
34.
Zurück zum Zitat Ray MA, Fehnel C, Akinbobola O, et al. Comparative effectiveness of a lymph node collection kit versus heightened awareness on lung cancer surgery quality and outcomes. J Thorac Oncol. 2021;16(5):774–83.CrossRefPubMedPubMedCentral Ray MA, Fehnel C, Akinbobola O, et al. Comparative effectiveness of a lymph node collection kit versus heightened awareness on lung cancer surgery quality and outcomes. J Thorac Oncol. 2021;16(5):774–83.CrossRefPubMedPubMedCentral
Metadaten
Titel
A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients
verfasst von
Zihuai Wang, MD
Zhenyu Yang, MD
Sijia Li, MD
Junqi Zhang, MD
Liang Xia, MD
Jian Zhou, MD
Nan Chen, MD
Chenglin Guo, MD
Lunxu Liu, MD, PhD, FRCS
Publikationsdatum
18.08.2022
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-022-12363-w

Weitere Artikel der Ausgabe 13/2022

Annals of Surgical Oncology 13/2022 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.